Parry-Romberg syndrome: follow-up imaging during suppressive therapy

Neuroradiology. 1997 Dec;39(12):873-6. doi: 10.1007/s002340050525.

Abstract

Parry-Romberg syndrome is a poorly--understood disorder characterized by progressive hemifacial atrophy involving the skin, soft tissue, and bone. Involvement of the central nervous system with impairment in neurologic function occurs infrequently. We describe a child with this syndrome in whom central nervous system involvement, documented on serial MRI, played a prominent role. We have attempted to correlate the clinical course with the radiologic findings, and to determine the impact of prednisone and methotrexate on the intracranial lesions.

Publication types

  • Case Reports

MeSH terms

  • Brain / pathology*
  • Child
  • Facial Hemiatrophy / drug therapy*
  • Facial Hemiatrophy / pathology*
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Magnetic Resonance Imaging*
  • Methotrexate / therapeutic use*
  • Prednisone / therapeutic use*

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Prednisone
  • Methotrexate